1Kupfer DJ, Frank E, Perel JM, Cornes C, et al. Five-year outcome of maintenance therapies in recurrent depression. Arch Gen Psychiatry,1992, 49 : 769～773
2NIMH Consensus Development Conference Statement. Mood disorder: pharmacologic prevention of recurrences. Am J Psychiatry,1985,142:469～476
4Frank E, Kupfer DJ, Perel JM, et al. Three-year outcome of maintenance therapies in recurrent depression. Arch Gen Psychiatry, 1990, 47 : 1093～1099
5Demyttenaere K. Risk factors and predictors of compliance in depression. European Neuropsychopharmacology, 2003, 13 (suppl ) : 69～75
6Demyttenaere K. Compliance during treatment with depressants. J Affect Disord, 1997, 43 : 27～39
7Thompson C, Peveler RC, Stephenson D, et al. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and tricyclic antidepressant. Am J Psychiatry, 2000, 157(3) : 338～343
8Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. J Clin Psychiatry, 2001, 62 (suppl 22) : 30～33
9Simon GE, Von Korff M, Wagner EH, et al. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry, 1993, 15 : 399～408
10Kroenke K, West SL, Swindle R, et al. Similar effectiveness of paraxetine, fluoxetine and sertraline in primary care: a randomized trial. J Am Med Assoc, 2001, 286 : 2947～2955
